Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Antibody discovery and engineering by enhanced CRISPR-Cas9 integration of variable gene cassette libraries in mammalian cells.

Parola C, Neumeier D, Friedensohn S, Csepregi L, Di Tacchio M, Mason DM, Reddy ST.

MAbs. 2019 Sep 16:1-14. doi: 10.1080/19420862.2019.1662691. [Epub ahead of print]

PMID:
31478465
2.

The center of olfactory bulb-seeded α-synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice.

Mason DM, Wang Y, Bhatia TN, Miner KM, Trbojevic SA, Stolz JF, Luk KC, Leak RK.

Brain Pathol. 2019 Mar 10. doi: 10.1111/bpa.12718. [Epub ahead of print]

PMID:
30854742
3.

Genome Engineering of Hybridomas to Generate Stable Cell Lines for Antibody Expression.

Parola C, Mason DM, Zingg A, Neumeier D, Reddy ST.

Methods Mol Biol. 2018;1850:79-111. doi: 10.1007/978-1-4939-8730-6_7.

PMID:
30242682
4.

High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis.

Mason DM, Weber CR, Parola C, Meng SM, Greiff V, Kelton WJ, Reddy ST.

Nucleic Acids Res. 2018 Aug 21;46(14):7436-7449. doi: 10.1093/nar/gky550.

5.

Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.

Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK.

Exp Neurol. 2018 Jan;299(Pt A):172-196. doi: 10.1016/j.expneurol.2017.10.017. Epub 2017 Oct 19.

6.

Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder.

Fayad SM, Guzick AG, Reid AM, Mason DM, Bertone A, Foote KD, Okun MS, Goodman WK, Ward HE.

PLoS One. 2016 Dec 8;11(12):e0167875. doi: 10.1371/journal.pone.0167875. eCollection 2016.

7.

Erratum to: Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe.

Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK.

Mol Neurodegener. 2016 Jul 27;11(1):57. No abstract available.

8.

Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe.

Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK.

Mol Neurodegener. 2016 Jun 30;11(1):49. doi: 10.1186/s13024-016-0113-4. Erratum in: Mol Neurodegener. 2016 Jul 27;11(1):57.

9.

Caring for the Unseen: Using Linking Social Capital to Improve Healthcare Access to Irregular Migrants in Spain.

Mason DM.

J Nurs Scholarsh. 2016 Sep;48(5):448-55. doi: 10.1111/jnu.12228. Epub 2016 Jun 29.

10.

Synergistic stress exacerbation in hippocampal neurons: Evidence favoring the dual-hit hypothesis of neurodegeneration.

Heinemann SD, Posimo JM, Mason DM, Hutchison DF, Leak RK.

Hippocampus. 2016 Aug;26(8):980-94. doi: 10.1002/hipo.22580. Epub 2016 Mar 29.

11.

Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Nouraei N, Zarger L, Weilnau JN, Han J, Mason DM, Leak RK.

Toxicol Appl Pharmacol. 2016 Apr 1;296:19-30. doi: 10.1016/j.taap.2016.02.010. Epub 2016 Feb 12.

12.

Childhood ADHD Symptoms: Association with Parental Social Networks and Mental Health Service Use during Adolescence.

Bussing R, Meyer J, Zima BT, Mason DM, Gary FA, Garvan CW.

Int J Environ Res Public Health. 2015 Sep 22;12(9):11893-909. doi: 10.3390/ijerph120911893.

13.

Heat shock protein responses to aging and proteotoxicity in the olfactory bulb.

Crum TS, Gleixner AM, Posimo JM, Mason DM, Broeren MT, Heinemann SD, Wipf P, Brodsky JL, Leak RK.

J Neurochem. 2015 Jun;133(6):780-794. doi: 10.1111/jnc.13041. Epub 2015 Mar 5.

14.
15.

A pilot study of actigraphy as an objective measure of SSRI activation symptoms: results from a randomized placebo controlled psychopharmacological treatment study.

Bussing R, Reid AM, McNamara JP, Meyer JM, Guzick AG, Mason DM, Storch EA, Murphy TK.

Psychiatry Res. 2015 Feb 28;225(3):440-5. doi: 10.1016/j.psychres.2014.11.070. Epub 2014 Dec 10.

16.

Use of structured expert judgment to forecast invasions by bighead and silver carp in Lake Erie.

Wittmann ME, Cooke RM, Rothlisberger JD, Rutherford ES, Zhang H, Mason DM, Lodge DM.

Conserv Biol. 2015 Feb;29(1):187-97. doi: 10.1111/cobi.12369. Epub 2014 Aug 7.

17.

Out-of-sample validation for structured expert judgment of Asian carp establishment in Lake Erie.

Cooke RM, Wittmann ME, Lodge DM, Rothlisberger JD, Rutherford ES, Zhang H, Mason DM.

Integr Environ Assess Manag. 2014 Oct;10(4):522-8. doi: 10.1002/ieam.1559.

18.

Adapting qualitative research strategies to technology savvy adolescents.

Mason DM, Ide B.

Nurse Res. 2014 May;21(5):40-5. doi: 10.7748/nr.21.5.40.e1241.

PMID:
24877910
19.

Feasibility of School-Based ADHD Interventions: A Mixed-Methods Study of Perceptions of Adolescents and Adults.

Bussing R, Koro-Ljungberg M, Gagnon JC, Mason DM, Ellison A, Noguchi K, Garvan CW, Albarracin D.

J Atten Disord. 2016 May;20(5):400-13. doi: 10.1177/1087054713515747. Epub 2014 Jan 21.

20.

Holism and embodiment in nursing: using Goethean science to join 2 perspectives on patient care.

Mason DM.

Holist Nurs Pract. 2014 Jan-Feb;28(1):55-64. doi: 10.1097/HNP.0000000000000010.

PMID:
24304632
21.

Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.

Meyer JM, McNamara JP, Reid AM, Storch EA, Geffken GR, Mason DM, Murphy TK, Bussing R.

Child Psychiatry Hum Dev. 2014;45(2):163-72. doi: 10.1007/s10578-013-0388-4.

PMID:
23756717
22.

ADHD knowledge, perceptions, and information sources: perspectives from a community sample of adolescents and their parents.

Bussing R, Zima BT, Mason DM, Meyer JM, White K, Garvan CW.

J Adolesc Health. 2012 Dec;51(6):593-600. doi: 10.1016/j.jadohealth.2012.03.004. Epub 2012 Apr 17.

23.

Receiving treatment for attention-deficit hyperactivity disorder: do the perspectives of adolescents matter?

Bussing R, Zima BT, Mason DM, Porter PC, Garvan CW.

J Adolesc Health. 2011 Jul;49(1):7-14. doi: 10.1016/j.jadohealth.2010.08.014. Epub 2010 Oct 20.

24.

Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample.

Bussing R, Mason DM, Bell L, Porter P, Garvan C.

J Am Acad Child Adolesc Psychiatry. 2010 Jun;49(6):595-605. doi: 10.1016/j.jaac.2010.03.006. Epub 2010 May 1.

25.

Density-dependent habitat selection and performance by a large mobile reef fish.

Lindberg WJ, Frazer TK, Portier KM, Vose F, Loftin J, Murie DJ, Mason DM, Nagy B, Hart MK.

Ecol Appl. 2006 Apr;16(2):731-46.

PMID:
16711059
26.

Exploring help-seeking for ADHD symptoms: a mixed-methods approach.

Bussing R, Koro-Ljungberg ME, Gary F, Mason DM, Garvan CW.

Harv Rev Psychiatry. 2005 Mar-Apr;13(2):85-101.

PMID:
16020023
27.

Compartments revealed in food-web structure.

Krause AE, Frank KA, Mason DM, Ulanowicz RE, Taylor WW.

Nature. 2003 Nov 20;426(6964):282-5.

28.

Agreement between CASA parent reports and provider records of children's ADHD services.

Bussing R, Mason DM, Leon CE, Sinha K.

J Behav Health Serv Res. 2003 Oct-Dec;30(4):462-9.

PMID:
14593669
29.

Social networks, caregiver strain, and utilization of mental health services among elementary school students at high risk for ADHD.

Bussing R, Zima BT, Gary FA, Mason DM, Leon CE, Sinha K, Garvan CW.

J Am Acad Child Adolesc Psychiatry. 2003 Jul;42(7):842-50.

PMID:
12819444
30.

Child temperament, ADHD, and caregiver strain: exploring relationships in an epidemiological sample.

Bussing R, Gary FA, Mason DM, Leon CE, Sinha K, Garvan CW.

J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):184-92.

PMID:
12544178
31.

Effects of habitat destruction and resource supplementation in a predator-prey metapopulation model.

Swihart RK, Feng Z, Slade NA, Mason DM, Gehring TM.

J Theor Biol. 2001 Jun 7;210(3):287-303.

PMID:
11397130
32.

Duane retraction syndrome associated with Rubinstein-Taybi syndrome.

Cruz OA, Mason DM, Eswara MS, Lueder GT.

Ophthalmic Genet. 1995 Dec;16(4):171-5.

PMID:
8749054
33.

Strength-interval relation for ventricular functional refractoriness.

Liem LB, Mason DM Jr, Swerdlow CD.

Am J Cardiol. 1988 Jan 1;61(1):88-92.

PMID:
3337023
34.

Verapamil decreases MAC for halothane in dogs.

Maze M, Mason DM Jr, Kates RE.

Anesthesiology. 1983 Oct;59(4):327-9.

PMID:
6614542
35.

Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.

Brereton HD, Halushka PV, Alexander RW, Mason DM, Keiser HR, DeVita VT Jr.

N Engl J Med. 1974 Jun 11;291(2):83-5.

PMID:
4835887
36.

Variola minor.

Welch EM, Mason DM.

Nurs Times. 1966 Jul 15;62(28):928-30. No abstract available.

PMID:
5939180
37.

THE ADOLESCENT MOTHER.

MASON DM.

N Z Med J. 1965 Jun;64:SUPPL:22-4. No abstract available.

PMID:
14328124
38.

BRONCHOGENIC CARCINOMA WITH INAPPROPRIATE ANTIDIURETIC ACTIVITY IN PLASMA AND TUMOR.

BOWER BF, MASON DM, FORSHAM PH.

N Engl J Med. 1964 Oct 29;271:934-8. No abstract available.

PMID:
14197415
39.

A capillary tube agglutination test for detecting antibodies against ornithosis in turkey serum.

MASON DM.

J Immunol. 1959 Dec;83:661-6. No abstract available.

PMID:
14422049
40.

Epidemiological features.

CHIN TD, HEIMLICH CR, WHITE RF, MASON DM, FURCOLOW ME.

Public Health Rep. 1957 Jun;72(6):512-8. No abstract available.

41.

An agglutination test for bovine Q fever performed on milk samples.

LUOTO L, MASON DM.

J Immunol. 1955 Mar;74(3):222-7. No abstract available.

PMID:
14354204

Supplemental Content

Loading ...
Support Center